CBDG (THC Farmaceuticals) EV-to-FCF: (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, THC Farmaceuticals's Enterprise Value is $0.24 Mil. THC Farmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2018 was $0.00 Mil. Therefore, THC Farmaceuticals's EV-to-FCF for today is .

The historical rank and industry rank for THC Farmaceuticals's EV-to-FCF or its related term are showing as below:

CBDG' s EV-to-FCF Range Over the Past 10 Years
Min: -28.79   Med: 0   Max: 2.47
Current: -12.53

During the past 4 years, the highest EV-to-FCF of THC Farmaceuticals was 2.47. The lowest was -28.79. And the median was 0.00.

CBDG's EV-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 15.51 vs CBDG: -12.53

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-18), THC Farmaceuticals's stock price is $0.024. THC Farmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 was $0.000. Therefore, THC Farmaceuticals's PE Ratio (TTM) for today is N/A.

THC Farmaceuticals  (OTCPK:CBDG) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

THC Farmaceuticals's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.024/0.000
=N/A

THC Farmaceuticals's share price for today is $0.024.
THC Farmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

THC Farmaceuticals EV-to-FCF Related Terms

THC Farmaceuticals EV-to-FCF Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals EV-to-FCF Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
EV-to-FCF
0.00 0.00 0.00 0.00

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBDG vs BOXS: EV-to-FCF Comparison

For the Biotechnology subindustry, THC Farmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Farmaceuticals EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, THC Farmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where THC Farmaceuticals's EV-to-FCF falls into.


THC Farmaceuticals EV-to-FCF Calculation

THC Farmaceuticals's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.238/0
=

THC Farmaceuticals's current Enterprise Value is $0.24 Mil.
THC Farmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.